MAP1LC3A and hepatocellular carcinoma: LC3 was found to be related to tumor growth and progression of triple negative breast cancer (22), and be associated with clinical prognosis of pancreatic cancer (23), hepatocellular carcinoma (24) and colorectal cancer (25).